Galmed Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLMD and other ETFs, options, and stocks.

About GLMD

Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. 

CEO
Allen Baharaff
CEOAllen Baharaff
Employees
6
Employees6
Headquarters
Ramat Gan, Tel Aviv
HeadquartersRamat Gan, Tel Aviv
Founded
2000
Founded2000
Employees
6
Employees6

GLMD Key Statistics

Market cap
3.61M
Market cap3.61M
Price-Earnings ratio
-0.18
Price-Earnings ratio-0.18
Dividend yield
—
Dividend yield—
Average volume
126.26K
Average volume126.26K
High today
$1.67
High today$1.67
Low today
$1.53
Low today$1.53
Open price
$1.62
Open price$1.62
Volume
32.68K
Volume32.68K
52 Week high
$23.80
52 Week high$23.80
52 Week low
$1.21
52 Week low$1.21
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.